Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis

CONCLUSION: Despite advent of treatments with different MOA, cycling between treatments with the same MOA was common. Further studies with longer data follow-up would be needed to assess the impact of higher adoption of biosimilars on treatment patterns/sequencing.PMID:34544301 | DOI:10.1080/03007995.2021.1981278

Source: Current Medical Research and Opinion - September 21, 2021 Category: Research Authors: Genevieve Gauthier Rebecca Levin Francis Vekeman Juan Manuel Reyes Esteban Chiarello Dario Ponce de Leon Source Type: research